Earnings and valuation of Box Inc (BOX) Stock are impressive

Morgan Stanley lowered the price target for the Box Inc (NYSE:BOX) stock from “an Overweight” to “an Equal-weight”. The rating was released on May 22, 2024, according to finviz. The stock was downgraded by RBC Capital Mkts, who disclosed in a research note on January 10, 2023, from Sector Perform to Underperform and set the […]

Cognex Corp. (CGNX) Stock Experiences Incredible Growth

HSBC Securities raised the price target for the Cognex Corp. (NASDAQ:CGNX) stock from “a Hold” to “a Buy”. The rating was released on May 07, 2024, according to finviz. We previously noted in another research note published on March 19, 2024 by UBS that upgraded the stock from a Neutral to a Buy with a […]

Ecopetrol SA ADR (EC) Stock is more thoughtful than you think

BofA Securities raised the price target for the Ecopetrol SA ADR (NYSE:EC) stock from “a Neutral” to “an Underperform”. The rating was released on May 30, 2024, according to finviz. We previously noted in another research note published on March 04, 2024 by Morgan Stanley that downgraded the stock from an Equal-weight to an Underweight […]

Is Costar Group, Inc. (CSGP) Stock A Better Investment Than Its Rivals?

Citigroup raised the price target for the Costar Group, Inc. (NASDAQ:CSGP) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Goldman has resumed the stock to Buy, with a price target set at $98. The stock was resumed by Jefferies, who disclosed in a research […]

Are Options A Good Investment Right Now? Newmont Corp (NEM) Stock

Jefferies raised the price target for the Newmont Corp (NYSE:NEM) stock to “a Buy”. The rating was released on February 29, 2024, according to finviz. The stock was initiated by Macquarie, who disclosed in a research note on November 21, 2023, to Outperform and set the price objective to $45. In their research brief published […]

The future of Vertex Pharmaceuticals, Inc. (VRTX) Stock is still in tatters?

Evercore ISI raised the price target for the Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX) stock from “an In-line” to “an Outperform”. The rating was released on April 11, 2024, according to finviz. The research report from Evercore ISI has downgraded the stock from Outperform to In-line, with a price target set at $438. In their research brief […]

A New Look at Vishay Intertechnology, Inc. (VSH) Stock’s Hidden Strategies

Loop Capital raised the price target for the Vishay Intertechnology, Inc. (NYSE:VSH) stock from “a Hold” to “a Buy”. The rating was released on April 06, 2021, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $20. The stock was upgraded by […]